Effects of Timed Restricted Eating on Body Composition, Metabolism, and Cardiovascular Health
The Effect of Timed Restricted Eating With or Without Intermittent Energy Restriction on Measures of Body Composition, Resting Energy Expenditure, Cardiovascular Modulation, and Blood Biomarkers Over 12 Weeks
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study is looking at whether eating all meals within a 6-hour window each day (called Time-Restricted Eating, or TRE) can improve body composition, metabolism, heart health, and blood markers over 12 weeks. The study also wants to find out whether allowing participants to eat normally on weekends makes the diet easier to follow long-term. Adults aged 18-65 with a BMI of 26 or higher who do not have heart disease or diabetes may be eligible. Participants will be randomly placed into one of two groups: (1) TRE every day for 12 weeks, or (2) TRE on weekdays with normal eating on weekends. All participants will visit the lab twice - once at the start and once at the end - for measurements of body fat, resting calorie burn, heart function, and blood tests. Between visits, participants will log their meals and steps at home and check in with the research team every two weeks.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2026
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 1, 2026
CompletedFirst Posted
Study publicly available on registry
May 7, 2026
CompletedStudy Start
First participant enrolled
July 1, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
Study Completion
Last participant's last visit for all outcomes
July 1, 2027
May 7, 2026
May 1, 2026
10 months
May 1, 2026
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Body Fat Percentage
Change in body fat percentage assessed via the 4-compartment (4C) model, combining DXA-derived bone mineral content, air displacement plethysmography (BodPod) body volume, bioimpedance spectroscopy (BIS) total body water, and calibrated body mass, using the Wang equation.
Baseline and 12 weeks
Study Arms (2)
TRE Only
EXPERIMENTALParticipants restrict all calorie-containing food and beverages to a 6-hour afternoon eating window (e.g., 2-8 pm) every day for 12 weeks. Outside of this window, only water, black coffee, and plain tea are permitted.
TRE + Weekend Ad Libitum (TRE+IER)
EXPERIMENTALParticipants restrict all calorie-containing food and beverages to the same 6-hour afternoon eating window Monday through Friday. On Saturday and Sunday, participants return to their regular, unrestricted eating habits. This arm tests whether periodic weekend diet breaks improve long-term dietary adherence while maintaining a meaningful weekly calorie deficit.
Interventions
Participants consume all calorie-containing food and beverages within a 6-hour afternoon eating window (e.g., 2-8 pm) every day for 12 weeks. Outside of this window, only non-caloric beverages (water, black coffee, plain tea) are permitted. No changes to food quality or caloric targets are prescribed.
Participants follow the same 6-hour afternoon eating window Monday through Friday. On Saturday and Sunday, participants return to their habitual, unrestricted eating pattern (ad libitum intake). This modified approach introduces periodic weekend diet breaks to assess whether reduced dietary rigidity improves long-term adherence while maintaining a clinically meaningful weekly calorie deficit.
Eligibility Criteria
You may qualify if:
- Between 18 and 65 years of age Body mass index (BMI) of 26 kg/m² or higher (overweight or obese range) Physically inactive, defined as 150 minutes or less of moderate-intensity physical activity per week for the 3 months prior to enrollment No previous history of cardiovascular disease or Type 1 or Type 2 Diabetes Mellitus Not currently taking medications that may affect blood sugar, cholesterol, or body weight (e.g., glucose-lowering drugs, statins, or weight loss medications) Weight stable, defined as no more than 5 kg (about 11 lbs.) of body weight change in the 3 months prior to enrollment Willing and able to follow the study requirements, provide voluntary consent, and complete all study procedures
You may not qualify if:
- Younger than 18 or older than 65 years of age BMI below 26 kg/m² More than 150 minutes per week of moderate-intensity physical activity in the past 3 months History of cardiovascular disease or Type 1 or Type 2 Diabetes Mellitus Currently taking medications that may impact study outcomes Weight change of more than 5 kg in the past 3 months Pregnant, breastfeeding, or planning to become pregnant during the study History of an eating disorder Previous weight loss surgery (e.g., gastric bypass or sleeve gastrectomy) Unable to fast for approximately 18 hours at a time due to a medical condition Currently working night shifts Has a pacemaker or any implanted electronic device (due to bioimpedance spectroscopy testing) Any health condition the research team determines would put the participant at risk
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
May 1, 2026
First Posted
May 7, 2026
Study Start (Estimated)
July 1, 2026
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
July 1, 2027
Last Updated
May 7, 2026
Record last verified: 2026-05